Loading icon
Categories
Bioinformatics
2
Genetics
10
Art and Literature
3
Tutorials
6
Multiple Sclerosis
5
Omics
2
Trending post
1
Predicting Multiple Sclerosis: Scientific Promise, Clinical Limits, and Future Opportunities
Genetics
Predicting Multiple Sclerosis: Scientific Promise, Clinical Limits, and Future Opportunities

07, Jun 2026

2
Predicting Multiple Sclerosis: Scientific Promise, Clinical Limits, and Future Opportunities
Genetics
Gene–Environment Interactions in Multiple Sclerosis: Insights from UK Biobank

06, Jun 2026

3
Polygenic Risk Scoring for Multiple Sclerosis: Ancestry-Dependent Performance and the Need for Equitable Genomic Prediction
Genetics
Polygenic Risk Scoring for Multiple Sclerosis: Ancestry-Dependent Performance and the Need for Equitable Genomic Prediction

05, Jun 2026

4
Genetic Architecture of Multiple Sclerosis Across South Asian and African Ancestries
Genetics
Genetic Architecture of Multiple Sclerosis Across South Asian and African Ancestries

04, Jun 2026

5
Polygenic Risk Scores and the Lifetime Risk of Multiple Sclerosis: Insights from a Dutch Birth-Year Cohort
Genetics
Polygenic Risk Scores and the Lifetime Risk of Multiple Sclerosis: Insights from a Dutch Birth-Year Cohort

03, Jun 2026

Categories:
Genetics
Tissue Markers and Personalized Medicine and Treatment Response in Multiple Sclerosis
Genetics
Tissue Markers and Personalized Medicine and Treatment Response in Multiple Sclerosis

09, Jun 2025

Genetics and Drug Response in MS: Why Some Patients Benefit More from First-Line Treatments
Genetics
Genetics and Drug Response in MS: Why Some Patients Benefit More from First-Line Treatments

10, Jun 2025

Plasma GFAP: A Promising Biomarker for Disease Progression and Treatment Response in Secondary Progressive MS
Genetics
Plasma GFAP: A Promising Biomarker for Disease Progression and Treatment Response in Secondary Progressive MS

11, Jun 2025

Could Paraoxonase1 (PON1) Be the Unsung Hero in Multiple Sclerosis Treatment Monitoring?
Genetics
Could Paraoxonase1 (PON1) Be the Unsung Hero in Multiple Sclerosis Treatment Monitoring?

12, Jun 2025